A patient in New York has been infected with a strain of E. coli highly resistant to last-resort antibiotic treatments, according to an article on the Becker's Infection Control and Clinical Quality website.
This is the second U.S. patient with the untreatable superbug infection, following a Pennsylvania patient first made public last month.
The mcr-1 gene gives bacteria resistance to colistin, a last-line-of-defense antibiotic used to combat a number of resistant microorganisms.
Going into 2017, the White House has requested $1.1 billion be allocated to efforts to combat antibiotic resistance in the U.S.
What To Know Now About OSHA's Updated Hazcom Rule
HealthSource of Ohio and UC Health Partner for New Medical Office Building
NorthShore Health Centers Investigates Data Security Incident 
Healthcare Ransomware Attacks Reach Record High in Q3 2026
Bon Secours Mercy Health Acquires Fauquier Health